Journey Medical Corp. (DERM), a commercial-stage pharmaceutical company headquartered in Scottsdale, Arizona, is drawing attention with steady gains in recent trading. The company specializes in dermatological treatments, offering a portfolio that includes Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm, Targadox, Emrosi, and Luxamend. Its focus on both established therapies and new product launches positions it as an active player in the dermatology market.
Clinical Validation and Payer Expansion for Emrosi
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com